Boothbay Fund Management, LLC Astrazeneca PLC Call Options Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $3.88 Million - $4.7 Million	-58,100 Reduced 64.63%	31,800 $2.48 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $5.49 Million - $6.25 Million	89,900 New	89,900 $6.09 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $16.7 Million - $18.1 Million	238,300 Added 222.71%	345,300 $24.7 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $6.76 Million - $7.66 Million	107,000 New	107,000 $7.43 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $545,602 - $644,683	-10,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $561,156 - $613,979	10,100 New	10,100 $607,000

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.